Literature DB >> 19386709

Activated Ras/MEK inhibits the antiviral response of alpha interferon by reducing STAT2 levels.

Sherri L Christian1, Thaddeus W Collier, Dong Zu, Maria Licursi, Chris M Hough, Kensuke Hirasawa.   

Abstract

The ability of interferon (IFN) to induce the expression of antiviral genes, and therefore suppress viral infection, is dependent on the activity of cellular suppressors. The Ras/MEK pathway is one of these cellular suppressors, since the activation of Ras/MEK permits viral replication in the presence of alpha IFN (IFN-alpha). Here, we have investigated the mechanism by which activated Ras/MEK inhibits the IFN-alpha response. We found that the induction of antiviral proteins in response to IFN-alpha was impaired in Ras-transformed NIH 3T3 (RasV12) cells. The inhibition of the Ras/MEK pathway restored the IFN-mediated induction of antiviral genes, indicating that activated Ras interrupts the IFN pathway upstream of antiviral gene transcription. Indeed, the IFN-induced phosphorylation of signal transducer and activator of transcription 1 (STAT1) and STAT2 was inhibited in RasV12 cells compared to that of vector control cells. In addition, we found that the total amount of STAT2 was reduced in RasV12 cells. To determine if the impaired IFN-alpha response can be rescued by restoring the overall level of STAT2, we overexpressed STAT2 in RasV12 cells. The IFN-alpha-induced phosphorylation of STAT1 and STAT2, as well as the expression of antiviral protein, were restored, and IFN-induced antiviral protection was partially restored. Moreover, we demonstrated that the downregulation of STAT2 levels by Ras/MEK was mediated at the transcriptional level. Thus, the activation of the Ras/MEK pathway reduces the amount of STAT2 available for propagating the IFN signal, resulting in the impairment of the IFN-alpha-induced antiviral response.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19386709      PMCID: PMC2698556          DOI: 10.1128/JVI.02213-08

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  52 in total

Review 1.  Viruses and interferons.

Authors:  G C Sen
Journal:  Annu Rev Microbiol       Date:  2001       Impact factor: 15.500

2.  Visna virus-induced activation of MAPK is required for virus replication and correlates with virus-induced neuropathology.

Authors:  Sheila A Barber; Linda Bruett; Brian R Douglass; David S Herbst; M Christine Zink; Janice E Clements
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

3.  A genetically engineered influenza A virus with ras-dependent oncolytic properties.

Authors:  M Bergmann; I Romirer; M Sachet; R Fleischhacker; A García-Sastre; P Palese; K Wolff; H Pehamberger; R Jakesz; T Muster
Journal:  Cancer Res       Date:  2001-11-15       Impact factor: 12.701

4.  Coxsackievirus B3 replication is reduced by inhibition of the extracellular signal-regulated kinase (ERK) signaling pathway.

Authors:  Honglin Luo; Bobby Yanagawa; Jingchun Zhang; Zongshu Luo; Mary Zhang; Mitra Esfandiarei; Christopher Carthy; Janet E Wilson; Decheng Yang; Bruce M McManus
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

5.  Oncolytic reovirus against ovarian and colon cancer.

Authors:  Kensuke Hirasawa; Sandra G Nishikawa; Kara L Norman; Tommy Alain; Anna Kossakowska; Patrick W K Lee
Journal:  Cancer Res       Date:  2002-03-15       Impact factor: 12.701

6.  MEK-specific inhibitor U0126 blocks spread of Borna disease virus in cultured cells.

Authors:  O Planz; S Pleschka; S Ludwig
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

7.  Oncogenes in Ras signalling pathway dictate host-cell permissiveness to herpes simplex virus 1.

Authors:  F Farassati; A D Yang; P W Lee
Journal:  Nat Cell Biol       Date:  2001-08       Impact factor: 28.824

Review 8.  Development of anticancer drugs targeting the MAP kinase pathway.

Authors:  J S Sebolt-Leopold
Journal:  Oncogene       Date:  2000-12-27       Impact factor: 9.867

Review 9.  Antiviral actions of interferons.

Authors:  C E Samuel
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

Review 10.  MAP kinase signalling pathways in cancer.

Authors:  A S Dhillon; S Hagan; O Rath; W Kolch
Journal:  Oncogene       Date:  2007-05-14       Impact factor: 9.867

View more
  22 in total

Review 1.  The role of signal transducer and activator of transcription-2 in the interferon response.

Authors:  Håkan C Steen; Ana M Gamero
Journal:  J Interferon Cytokine Res       Date:  2012-01-26       Impact factor: 2.607

2.  Epigenomic Reordering Induced by Polycomb Loss Drives Oncogenesis but Leads to Therapeutic Vulnerabilities in Malignant Peripheral Nerve Sheath Tumors.

Authors:  John B Wojcik; Dylan M Marchione; Simone Sidoli; Anissa Djedid; Amanda Lisby; Jacek Majewski; Benjamin A Garcia
Journal:  Cancer Res       Date:  2019-03-21       Impact factor: 12.701

3.  Oncogenic Ras inhibits IRF1 to promote viral oncolysis.

Authors:  Y Komatsu; S L Christian; N Ho; T Pongnopparat; M Licursi; K Hirasawa
Journal:  Oncogene       Date:  2014-10-27       Impact factor: 9.867

4.  Activation of the Ras/Raf/MEK pathway facilitates hepatitis C virus replication via attenuation of the interferon-JAK-STAT pathway.

Authors:  Qi Zhang; Rui Gong; Jing Qu; Yijing Zhou; Weiyong Liu; Mingzhou Chen; Yingle Liu; Ying Zhu; Jianguo Wu
Journal:  J Virol       Date:  2011-11-23       Impact factor: 5.103

5.  Ras transformation results in cleavage of reticulon protein Nogo-B that is associated with impairment of IFN response.

Authors:  Dae-Gyun Ahn; Tanveer Sharif; Kenneth Chisholm; Devanand M Pinto; Shashi A Gujar; Patrick W K Lee
Journal:  Cell Cycle       Date:  2015-05-06       Impact factor: 4.534

6.  Body temperature variation controls pre-mRNA processing and transcription of antiviral genes and SARS-CoV-2 replication.

Authors:  Bruna Los; Marco Preußner; Kathrin Eschke; Ricardo Martin Vidal; Azza Abdelgawad; Didrik Olofsson; Sandra Keiper; Margarida Paulo-Pedro; Alica Grindel; Stefan Meinke; Jakob Trimpert; Florian Heyd
Journal:  Nucleic Acids Res       Date:  2022-06-17       Impact factor: 19.160

Review 7.  The Regulatory Role of Reticulons in Neurodegeneration: Insights Underpinning Therapeutic Potential for Neurodegenerative Diseases.

Authors:  Lilesh Kumar Pradhan; Saroj Kumar Das
Journal:  Cell Mol Neurobiol       Date:  2020-06-05       Impact factor: 5.046

8.  Suppression of IFN-induced transcription underlies IFN defects generated by activated Ras/MEK in human cancer cells.

Authors:  Sherri L Christian; Dong Zu; Maria Licursi; Yumiko Komatsu; Theerawat Pongnopparat; Dianne A Codner; Kensuke Hirasawa
Journal:  PLoS One       Date:  2012-09-07       Impact factor: 3.240

9.  Effect of human activated NRAS on replication of delNS1 H5N1 influenza virus in MDCK cells.

Authors:  Jiping Zhu; HongBo Zhou; Wei Zou; MeiLin Jin
Journal:  Virol J       Date:  2011-05-19       Impact factor: 4.099

10.  PCBP2 enhances the antiviral activity of IFN-α against HCV by stabilizing the mRNA of STAT1 and STAT2.

Authors:  Zhongshuai Xin; Wei Han; Zhiqiang Zhao; Qing Xia; Bin Yin; Jiangang Yuan; Xiaozhong Peng
Journal:  PLoS One       Date:  2011-10-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.